Protara Therapeutics, Inc.

TARA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Aug 13, 2026
S-8 Aug 11, 2026 REGISTRATION STATEMENT
10-Q Aug 11, 2026 QUARTERLY REPORT
8-K Aug 11, 2026 CURRENT REPORT
SCHEDULE 13G/A Jul 7, 2026
4 Jul 1, 2026 PRIMARY DOCUMENT
8-K Jun 29, 2026 CURRENT REPORT
144 Jun 29, 2026
4 Jun 16, 2026 PRIMARY DOCUMENT
4 Jun 16, 2026 PRIMARY DOCUMENT
4 Jun 16, 2026 PRIMARY DOCUMENT
4 Jun 16, 2026 PRIMARY DOCUMENT
4 Jun 16, 2026 PRIMARY DOCUMENT
4 Jun 16, 2026 PRIMARY DOCUMENT
4 Jun 16, 2026 PRIMARY DOCUMENT
4 Jun 16, 2026 PRIMARY DOCUMENT
8-K Jun 15, 2026 CURRENT REPORT
4 Jun 3, 2026 PRIMARY DOCUMENT
424B5 May 28, 2026 PROSPECTUS SUPPLEMENT
EFFECT May 22, 2026
CORRESP May 20, 2026
UPLOAD May 19, 2026
SCHEDULE 13G/A May 15, 2026
S-3 May 14, 2026 REGISTRATION STATEMENT
10-Q May 13, 2026 QUARTERLY REPORT
← Newer Page 1 of 33 · 809 filings Older →